NCT02699203

Brief Summary

In addition to its role as the major regulator of glucose uptake into peripheral tissues, the hormone insulin is also a primary regulator of fat storage and fat burning of the body. Mechanistic animal studies have shown that high insulin may be the initial trigger for weight gain and be the proximal cause of obesity. There is currently no quick or non-invasive way of measuring insulin as research and clinical techniques require collection of a blood sample followed by a complicated and costly biochemical assay. The investigators will test the hypothesis that insulin levels can be accurately measured in saliva in humans following meals that elicit high and low blood insulin responses. Findings will help determine if insulin can be use as a valid fluid to track insulin changes in humans.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2015

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2015

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

February 22, 2016

Completed
11 days until next milestone

First Posted

Study publicly available on registry

March 4, 2016

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2016

Completed
Last Updated

March 17, 2017

Status Verified

February 1, 2016

Enrollment Period

7 months

First QC Date

February 22, 2016

Last Update Submit

March 16, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Peak plasma insulin level

    Peak plasma insulin concentration in high carbohydrate versus low carbohydrate arm.

    0-120 minutes

Secondary Outcomes (6)

  • Plasma insulin area under the curve

    0-120 minutes

  • Relationship between peak saliva and peak plasma insulin

    0-120 minutes

  • Timing of peak saliva and peak plasma insulin

    0-120 minutes

  • Relationship between saliva insulin area under the curve and plasma insulin area under the curve

    0-120 minutes

  • Peak saliva insulin level

    0-120 minutes

  • +1 more secondary outcomes

Study Arms (2)

High-carbohydrate meal

EXPERIMENTAL

High carbohydrate breakfast meal consisting of oatmeal and berries.

Behavioral: High-carbohydrate meal

Low-carbohydrate meal

EXPERIMENTAL

Low carbohydrate breakfast meal consisting of eggs and avocado.

Behavioral: Low-carbohydrate meal

Interventions

Participants will consume a high-carbohydrate low fat meal. The macronutrients content will be 55% carbohydrate, 25% protein and 20% fat providing 400-500 kcal. Between interventions there will be at least a 48-hours washout, where participants are encouraged to return to their baseline dietary habits.

High-carbohydrate meal

Participants will consume a low-carbohydrate high fat meal. The macronutrients content will be 10% carbohydrate, 25% protein and 65% fat and will provide 400-500 kcal (matched to the high carbohydrate meal). Between interventions there will be at least a 48-hours washout, where participants are encouraged to return to their baseline dietary habits.

Low-carbohydrate meal

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Body mass index between 18.5-24.9 or over 30.0 kg/m2

You may not qualify if:

  • Diabetes or other medical conditions affecting glucose or insulin levels
  • Smoker
  • Competitive athlete
  • Vegan or vegetarian

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of British Columbia, Okanagan.

Kelowna, British Columbia, V1V 1V7, Canada

Location

MeSH Terms

Conditions

Insulin Resistance

Condition Hierarchy (Ancestors)

HyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • Jonathan P Little, PhD

    University of British Columbia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 22, 2016

First Posted

March 4, 2016

Study Start

December 1, 2015

Primary Completion

July 1, 2016

Study Completion

July 1, 2016

Last Updated

March 17, 2017

Record last verified: 2016-02

Data Sharing

IPD Sharing
Will not share

Locations